Chun Kwok Alan Au
Chun Kwok Alan Au has served as our director since January 2020. Mr. Au is the founder of GT Healthcare, a private equity fund focusing on cross border healthcare investments and has served as its managing partner and director of affiliated group companies since September 2015. Previously, from 2011 to 2012, Mr. Au was the head of the Asia Healthcare Investment Banking of Deutsche Bank Group, advising healthcare IPOs and M&A in the region. Prior to that, from 2008 to 2010, Mr. Au served as an investment director at JAFCO Asia Investment Group, responsible for healthcare investments in China. Mr. Au was an investment director at Morningside Group overseeing healthcare investments in Asia and China from 2000 to 2005. Mr. Au has served as a member of the board of directors, and the chairman of the Audit Committee of CSPC Pharmaceutical Group (HKEX: 1093), a leading pharmaceutical group in China, since January 2021. Mr. Au also served as an independent non-executive director of TJ Biopharma since January 2021. He also served as a member of the board of directors of Cellular BioMedicine Group. Mr. Au was a panel member for the Innovation and Technology Fund of the Hong Kong SAR Government from 2014 to 2022. Mr. Au earned a Bachelor’s in Psychology from Chinese University of Hong Kong in 1995 and a Master’s in Management from Columbia Business School in New York in 2007. Mr. Au is a certified public accountant (CPA) in the United States and a chartered financial analyst (CFA). He is a member of the Hong Kong Institute of Financial Analysts and member of the American Institute of Certified Public Accountants.